BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 14714858)

  • 1. Synthesis and antiproliferative activity in vitro of new 3-substituted aminoisoxazolo[5,4-b]pyridines.
    Poreba K; Wietrzyk J; Opolski A
    Acta Pol Pharm; 2003; 60(4):293-301. PubMed ID: 14714858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antiproliferative activity in vitro of new 3-substituted aminopyrazolo[3,4-b]pyridines.
    Poreba K; Opolski A; Wietrzyk J
    Acta Pol Pharm; 2002; 59(3):215-22. PubMed ID: 12230249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthesis of 3,5,6,7-tetrasubstituted isoxazolo[4,5-b]pyridines and an evaluation of their in vitro antiproliferative activity.
    Poreba K; Wietrzyk J
    Adv Clin Exp Med; 2012; 21(5):563-71. PubMed ID: 23356192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
    Poreba K; Wietrzyk J; Opolski A
    Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF NEW SULFONAMIDE ISOXAZOLO[5,4-b]PYRIDINE DERIVATIVES.
    Poręba K; Pawlik K; Rembacz KP; Kurowska E; Matuszyk J; Długosz A
    Acta Pol Pharm; 2015; 72(4):727-35. PubMed ID: 26647630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiproliferative activity in vitro of new pyrido[1,4-b]diazepine derivatives and imidazo[4,5-b]pyridine.
    Liszkiewicz H; Nawrocka WP; Sztuba B; Wietrzyk J; Jaroszewicz J; Nasulewicz A; Pełczyńska M
    Acta Pol Pharm; 2011; 68(3):349-55. PubMed ID: 21648189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient regioselective synthesis and potential antitumor evaluation of isoxazolo[5,4-b]pyridines and related annulated compounds.
    Hamama WS; Ibrahim ME; Zoorob HH
    Arch Pharm (Weinheim); 2012 Jun; 345(6):468-75. PubMed ID: 22383332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma.
    Kim HJ; Jung MH; Kim H; El-Gamal MI; Sim TB; Lee SH; Hong JH; Hah JM; Cho JH; Choi JH; Yoo KH; Oh CH
    Bioorg Med Chem Lett; 2010 Jan; 20(1):413-7. PubMed ID: 19897366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
    Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
    Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
    J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiproliferative activity of some N-sulphonated-2-substituted benzimidazoles and imidazo[4,5-b]pyridines.
    Garuti L; Varoli L; Cermelli C; Baggio G; Lupo L; Malagoli M; Castelli M
    Anticancer Drug Des; 1998 Dec; 13(8):969-80. PubMed ID: 10335270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiproliferative activity in vitro of new propargyl thioquinolines.
    Boryczka S; Wietrzyk J; Opolski A
    Pharmazie; 2002 Mar; 57(3):151-4. PubMed ID: 11933840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
    Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
    Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines.
    Willemann C; Grünert R; Bednarski PJ; Troschütz R
    Bioorg Med Chem; 2009 Jul; 17(13):4406-19. PubMed ID: 19481463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiproliferative activity in vitro of 2-aminobenzimidazole derivatives.
    Nawrocka W; Sztuba B; Kowalska MW; Liszkiewicz H; Wietrzyk J; Nasulewicz A; Pełczyńska M; Opolski A
    Farmaco; 2004 Feb; 59(2):83-91. PubMed ID: 14871499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiproliferative activity of some 5-substituted 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles.
    Matysiak J; Nasulewicz A; Pełczyńska M; Switalska M; Jaroszewicz I; Opolski A
    Eur J Med Chem; 2006 Apr; 41(4):475-82. PubMed ID: 16517026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
    Singh P; Kaur P; Luxami V; Kaur S; Kumar S
    Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. IV. Biological activity of variously substituted 2,3-diaryl-1,3-thiazolidin-4-ones.
    Piscopo E; Diurno MV; Gagliardi R; Mazzoni O; Veneruso G
    Boll Soc Ital Biol Sper; 1989 Sep; 65(9):853-9. PubMed ID: 2627344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and cytotoxic activities of 4,5-diarylisoxazoles.
    Sun CM; Lin LG; Yu HJ; Cheng CY; Tsai YC; Chu CW; Din YH; Chau YP; Don MJ
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1078-81. PubMed ID: 17127061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and antitumor activity of C3 heterocyclic-substituted fluoroquinolone derivatives (I): ciprofloxacin aminothiodiazole Schiff-bases].
    Hu GQ; Wu XK; Wang X; Zhang ZQ; Xie SQ; Huang WL; Zhang HB
    Yao Xue Xue Bao; 2008 Nov; 43(11):1112-5. PubMed ID: 19239029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.